Hennion & Walsh Asset Management Inc. grew its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 90.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 94,182 shares of the company's stock after purchasing an additional 44,700 shares during the period. Hennion & Walsh Asset Management Inc. owned approximately 0.25% of Crescent Capital BDC worth $1,742,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Point72 Asset Management L.P. acquired a new stake in shares of Crescent Capital BDC during the second quarter worth $90,000. XTX Topco Ltd purchased a new stake in Crescent Capital BDC during the second quarter valued at about $195,000. Alpine Global Management LLC purchased a new stake in Crescent Capital BDC during the first quarter valued at about $217,000. Catalina Capital Group LLC acquired a new position in shares of Crescent Capital BDC in the second quarter worth about $220,000. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of Crescent Capital BDC in the second quarter worth approximately $346,000. Institutional investors and hedge funds own 49.46% of the company's stock.
Analyst Ratings Changes
CCAP has been the subject of several research analyst reports. Bank of America reduced their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating for the company in a research report on Thursday, August 15th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a research report on Monday, September 30th. They issued a "buy" rating and a $20.00 target price for the company. Finally, Wells Fargo & Company dropped their price target on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 14th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $19.00.
Check Out Our Latest Stock Analysis on CCAP
Crescent Capital BDC Stock Down 0.6 %
Shares of NASDAQ CCAP traded down $0.11 during mid-day trading on Friday, reaching $18.39. The company had a trading volume of 71,272 shares, compared to its average volume of 132,821. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40. Crescent Capital BDC, Inc. has a twelve month low of $15.03 and a twelve month high of $19.63. The stock's 50 day moving average is $18.43 and its 200-day moving average is $18.30. The stock has a market capitalization of $681.57 million, a PE ratio of 6.54 and a beta of 0.81.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its earnings results on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.01. The company had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same period in the prior year, the firm posted $0.56 EPS. As a group, equities analysts anticipate that Crescent Capital BDC, Inc. will post 2.35 earnings per share for the current fiscal year.
Crescent Capital BDC Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th were paid a $0.42 dividend. The ex-dividend date of this dividend was Monday, September 30th. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a yield of 9.14%. Crescent Capital BDC's payout ratio is 59.79%.
About Crescent Capital BDC
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.